Page last updated: 2024-10-29

ketanserin and Uremia

ketanserin has been researched along with Uremia in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malyszko, J1
Pawlak, K1
Borawski, J1
Malyszko, JS1
Mysliwiec, M2
Azzadin, A1
Mysliwiec, J1
Wollny, T1
Buczko, W1

Other Studies

2 other studies available for ketanserin and Uremia

ArticleYear
Effect of ketanserin on platelet function and bleeding time in uremic patients treated with erythropoietin.
    Thrombosis research, 1995, Jun-15, Volume: 78, Issue:6

    Topics: Adult; Anemia; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Drug Monitoring; Er

1995
Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats.
    Thrombosis research, 1995, Feb-01, Volume: 77, Issue:3

    Topics: Anemia; Animals; Blood Platelets; Endothelium, Vascular; Erythropoietin; Hypertension; Ketanserin; K

1995